Chemotherapy News and Research

Latest Chemotherapy News and Research

FDA approves new therapy for initial treatment of soft tissue sarcoma

The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues.

19 Oct 2016

New clinical study to examine novel dietary approach for TNBC

A new clinical trial for women with clinically aggressive triple-negative breast cancer (TNBC) will test a novel theory: Will a diet low in an essential nutrient make TNBC cells more vulnerable to cell killing by a new cancer drug?

19 Oct 2016

Research could lead to new type of treatment for pancreatic cancer based on gold nanoparticles

A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease.

19 Oct 2016

Researchers find new path to stop metastatic growth of cancer

Investigators from the Research Institute of the McGill University Health Centre, and the Institute of Cancer Research, London, have discovered that some cancer cells can draw blood from existing mature blood vessels allowing them to continue to spread.

18 Oct 2016

CHLA receives grant to study effects of chemoimmunotherapy in childhood neuroblastoma

A team of investigators at Children's Hospital Los Angeles has received a major, three-year grant from the V Foundation for Cancer Research to study the effects of chemoimmunotherapy in children with neuroblastoma.

18 Oct 2016

Standard hormone supplement after radiotherapy could increase risk of prostate cancer recurrence

A new study at the University of York has shown that a standard hormone supplement, used to boost energy levels in prostate cancer patients following radiotherapy, could potentially increase the chances of the cancer returning.

18 Oct 2016

Chemotherapy leads to drug-resistance in bladder cancer patients

Chemotherapy is indicated as the first line of treatment for advanced bladder cancer. New research by Weill Cornell Medicine and University of Trento scientists shows that while chemotherapy kills the most common type of bladder cancer, urothelial cancer, chemotherapy also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant.

18 Oct 2016

New OU photothermal therapy may eliminate tumors without affecting healthy cells in the body

A staggering 1.7 million persons in the United States will be diagnosed with cancer in 2016, with 600,000 cases ending in death. University of Oklahoma researchers have collaborated to design a novel, non-invasive cancer therapy that could eliminate tumors without affecting the healthy cells in the body.

18 Oct 2016

CAPES program helps patients tell children about their illnesses

There was no question that Nancy Coronado would tell her two young children everything about her breast cancer diagnosis. She and her husband wanted to keep them informed of all aspects of treatment and care.

17 Oct 2016

New stem cell-based strategy may help predict heart-damaging effects of drugs

Coaxing stem cells from patients to become heart cells may help clinicians personalize drug treatments and prevent heart-related toxicity.

17 Oct 2016

UPV participates in Lumiblast project to develop novel treatments for hard-to-treat brain tumours

The Polytechnic University of Valencia is taking part in Lumiblast, a European project to develop an innovative approach to hard-to-treat brain tumours like glioblastomas.

14 Oct 2016

Yale researchers define genetic landscape of rare, aggressive carcinosarcomas

In a major breakthrough for ovarian and uterine cancers, Yale researchers have defined the genetic landscape of rare, highly aggressive tumors called carcinosarcomas (CSs), pointing the way to possible new treatments.

12 Oct 2016

New image analysis technique helps better identify and distinguish between two cancer cell types

Brown University researchers have developed a new image analysis technique to distinguish two key cancer cell types associated with tumor progression.

12 Oct 2016

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Fulvestrant significantly increases progression-free survival in women with hormone-receptor-positive advanced breast cancer, particularly those with less aggressive lower-volume disease, researchers reported at the ESMO 2016 Congress in Copenhagen

8 Oct 2016

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to full data from the ENGOT-OV16/NOVA trial presented for the first time at the ESMO 2016 Congress in Copenhagen and published in the New England Journal of Medicine.

8 Oct 2016

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Immunotherapy has shown promising results in first and second line treatment of metastatic bladder cancer in two phase II trials presented at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

Survey reveals inequalities in access to new, life saving drugs for melanoma in Europe

Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen.

7 Oct 2016

Researchers to explore potential roles of tumor-suppressor gene in kidney cancer

Renal cell carcinoma is the most common type of kidney cancer, and African-Americans and males appear most at risk for this disease that can be asymptomatic until it has spread and become highly lethal, said Dr. Vinata B. Lokeshwar, cancer researcher and chair of the Department of Biochemistry and Molecular Biology at the Medical College of Georgia at Augusta University.

7 Oct 2016

Study finds neoadjuvant immunotherapy safe, viable for early lung cancer patients before surgery

Neoadjuvant immunotherapy with the PD-1 inhibitor nivolumab is safe and feasible prior to surgery for early lung cancer, researchers reported at the ESMO 2016 Congress in Copenhagen.

7 Oct 2016

Increasing incidence of thyroid cancer in past three decades

The incidence of thyroid cancer has tripled in the past three decades, yet the reason for this is not clear.

6 Oct 2016

Chemotherapy News and Research

Latest Chemotherapy News and Research

FDA approves new therapy for initial treatment of soft tissue sarcoma

New clinical study to examine novel dietary approach for TNBC

Research could lead to new type of treatment for pancreatic cancer based on gold nanoparticles

Researchers find new path to stop metastatic growth of cancer

CHLA receives grant to study effects of chemoimmunotherapy in childhood neuroblastoma

Standard hormone supplement after radiotherapy could increase risk of prostate cancer recurrence

Chemotherapy leads to drug-resistance in bladder cancer patients

New OU photothermal therapy may eliminate tumors without affecting healthy cells in the body

CAPES program helps patients tell children about their illnesses

New stem cell-based strategy may help predict heart-damaging effects of drugs

UPV participates in Lumiblast project to develop novel treatments for hard-to-treat brain tumours

Yale researchers define genetic landscape of rare, aggressive carcinosarcomas

New image analysis technique helps better identify and distinguish between two cancer cell types

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

Immunotherapy redefines treatment approach for metastatic bladder cancer patients

Survey reveals inequalities in access to new, life saving drugs for melanoma in Europe

Researchers to explore potential roles of tumor-suppressor gene in kidney cancer

Study finds neoadjuvant immunotherapy safe, viable for early lung cancer patients before surgery

Increasing incidence of thyroid cancer in past three decades

Cancer Research - Second Edition eBook

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Newsletters you may be interested in